Comorbidities, Treatment and Survival Rates of Chronic Thromboembolic Pulmonary Hypertension in a Regional Centre
Abstract
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Delcroix, M.; Kerr, K.; Fedullo, P. Chronic Thromboembolic Pulmonary Hypertension. Epidemiology and Risk Factors. Ann. Am. Thorac. Soc. 2016, 13 (Suppl. S3), S201–S206. [Google Scholar] [CrossRef]
- Egermayer, P.; Peacock, A.J. Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. Eur. Respir. J. 2000, 15, 440–448. [Google Scholar] [CrossRef]
- Pepke-Zaba, J.; Delcroix, M.; Lang, I.; Mayer, E.; Jansa, P.; Ambroz, D.; Treacy, C.; D’Armini, A.M.; Morsolini, M.; Snijder, R.; et al. Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Circulation 2011, 124, 1973–1981. [Google Scholar] [CrossRef]
- Lang, I.M.; Madani, M. Update on Chronic Thromboembolic Pulmonary Hypertension. Circulation 2014, 130, 508–518. [Google Scholar] [CrossRef]
- Humbert, M.; Kovacs, G.; Hoeper, M.M.; Badagliacca, R.; Berger, R.M.F.; Brida, M.; Carlsen, J.; Coats, A.J.S.; Escribano-Subias, P.; Ferrari, P.; et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Respir. J. 2023, 61, 2200879. [Google Scholar] [CrossRef]
- Gopalan, D.; Delcroix, M.; Held, M. Diagnosis of chronic thromboembolic pulmonary hypertension. Eur. Respir. Rev. 2017, 26, 160108. [Google Scholar] [CrossRef]
- Swietlik, E.; Ruggiero, A.; Fletcher, A.J.; Taboada, D.; Knightbridge, E.; Harlow, L.; Harvey, I.; Screaton, N.; Cannon, J.E.; Sheares, K.K.; et al. Limitations of resting haemodynamics in chronic thromboembolic disease without pulmonary hypertension. Eur. Respir. J. 2019, 53, 1801787. [Google Scholar] [CrossRef]
- Carroll, D. Chronic obstruction of major pulmonary arteries. Am. J. Med. 1950, 9, 175–185. [Google Scholar] [CrossRef]
- Houk, V.N.; Hufnagel, C.A.; McClenathan, J.E.; Moser, K.M. Chronic thrombotic obstruction of major pulmonary arteries. Am. J. Med. 1963, 35, 269–282. [Google Scholar] [CrossRef]
- Ghofrani, H.A.; D’Armini, A.M.; Kim, N.H.; Mayer, E.; Simonneau, G. Interventional and pharmacological management of chronic thromboembolic pulmonary hypertension. Respir. Med. 2021, 177, 106293. [Google Scholar] [CrossRef]
- Luijten, D.; Talerico, R.; Barco, S.; Cannegieter, S.C.; Delcroix, M.; Ende-Verhaar, Y.M.; Huisman, M.V.; Konstantinidis, S.; Mairuhu, A.T.; van Mens, T.E.; et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: An updated systematic review and meta-analysis. Eur. Respir. J. 2023, 62, 2300449. [Google Scholar] [CrossRef]
- Hsieh, W.C.; Jansa, P.; Huang, W.C.; Nižnanský, M.; Omara, M.; Lindner, J. Residual pulmonary hypertension after pulmonary endarterectomy: A meta-analysis. J. Thorac. Cardiovasc. Surg. 2018, 156, 1275–1287. [Google Scholar] [CrossRef]
- Klok, F.A.; Couturaud, F.; Delcroix, M.; Humbert, M. Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Eur. Respir. J. 2020, 55, 2000189. [Google Scholar] [CrossRef]
- Klok, F.A.; van Kralingen, K.W.; van Dijk, A.P.J.; Heyning, F.H.; Vliegen, H.W.; Huisman, M.V. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica 2010, 95, 970–975. [Google Scholar] [CrossRef]
- Gall, H.; Hoeper, M.M.; Richter, M.J.; Cacheris, W.; Hinzmann, B.; Mayer, E. An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan. Eur. Respir. Rev. 2017, 26, 160121. [Google Scholar] [CrossRef]
- Leber, L.; Beaudet, A.; Muller, A. Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Identification of the most accurate estimates from a systematic literature review. Pulm. Circ. 2021, 11, 1–12. [Google Scholar] [CrossRef]
- Delcroix, M.; Torbicki, A.; Gopalan, D.; Sitbon, O.; Klok, F.A.; Lang, I.; Jenkins, D.; Kim, N.H.; Humbert, M.; Jais, X.; et al. ERS statement on chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2021, 57, 2002828. [Google Scholar] [CrossRef]
- Kramm, T.; Wilkens, H.; Fuge, J.; Schäfers, H.-J.; Guth, S.; Wiedenroth, C.B.; Weingard, B.; Huscher, D.; Pittrow, D.; Cebotari, S.; et al. Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany. Clin. Res. Cardiol. 2018, 107, 548–553. [Google Scholar] [CrossRef]
- Ende-Verhaar, Y.M.; Cannegieter, S.C.; Noordegraaf, A.V.; Delcroix, M.; Pruszczyk, P.; Mairuhu, A.T.A.; Huisman, M.V.; Klok, F.A. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: A contemporary view of the published literature. Eur. Respir. J. 2017, 49, 1601792. [Google Scholar] [CrossRef]
- Schweikert, B.; Pittrow, D.; Vizza, C.D.; Pepke-Zaba, J.; Hoeper, M.M.; Gabriel, A.; Berg, J.; Sikirica, M. Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: Retrospective results from six European countries. BMC Health Serv. Res. 2014, 14, 246. [Google Scholar] [CrossRef]
- Klok, F.A.; Barco, S.; Konstantinides, S.V.; Dartevelle, P.; Fadel, E.; Jenkins, D.; Kim, N.H.; Madani, M.; Matsubara, H.; Mayer, E.; et al. Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: Results from the European CTEPH Registry. Eur. Respir. J. 2018, 52, 1801687. [Google Scholar] [CrossRef] [PubMed]
- Kopeć, G.; Forfia, P.; Abe, K.; Beaudet, A.; Gressin, V.; Jevnikar, M.; Meijer, C.; Tan, Y.Z.; Moiseeva, O.; Sheares, K.; et al. Recognition, diagnosis, and operability assessment of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross-sectional scientific survey (CLARITY). Pulm. Circ. 2024, 14, e12330. [Google Scholar] [CrossRef]
- National Institute of Statistics (Romania). Population and Housing Census, 2021—Provisional Results [Internet]. 2022, p. 8. Available online: https://insse.ro/cms/en/content/population-and-housing-census-2021-provisional-results (accessed on 20 March 2024).
- Jansa, P.; Ambrož, D.; Kuhn, M.; Dytrych, V.; Aschermann, M.; Černý, V.; Gressin, V.; Heller, S.; Kunstýř, J.; Širanec, M.; et al. Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic. Pulm. Circ. 2022, 12, e12038. [Google Scholar] [CrossRef]
- Delcroix, M.; Staehler, G.; Gall, H.; Grünig, E.; Held, M.; Halank, M.; Klose, H.; Vonk-Noordegraaf, A.; Rosenkranz, S.; Pepke-Zaba, J.; et al. Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients. Eur. Respir. J. 2018, 52, 1800248. [Google Scholar] [CrossRef]
- Dardi, F.; Manes, A.; Guarino, D.; Suarez, S.M.; Loforte, A.; Rotunno, M.; Pacini, D.; Galiè, N.; Palazzini, M. Long-term outcomes after pulmonary endarterectomy. Ann. Cardiothorac. Surg. 2022, 11, 172–174. [Google Scholar] [CrossRef] [PubMed]
- Ruaro, B.; Baratella, E.; Caforio, G.; Confalonieri, P.; Wade, B.; Marrocchio, C.; Geri, P.; Pozzan, R.; Andrisano, A.G.; Cova, M.A.; et al. Chronic Thromboembolic Pulmonary Hypertension: An Update. Diagnostics 2022, 12, 235. [Google Scholar] [CrossRef]
- Ribas Sola, J.; Sánchez-Corral Mena, M.Á.; Riera-Mestre, A. Update in the management of chronic thrombo-embolic pulmonary hypertension. Med. Clín. (Engl. Ed.) 2024, 162, 126–133. [Google Scholar] [CrossRef]
- Nakazato, K.; Sugimoto, K.; Oikawa, M.; Takeishi, Y. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension:its history and development, and regional medical cooperation in Fukushima. Fukushima J. Med. Sci. 2023, 69, 167–176. [Google Scholar] [CrossRef]
- Darocha, S.; Roik, M.; Kopeć, G.; Araszkiewicz, A.; Furdal, M.; Lewandowski, M.; Jacheć, W.; Grabka, M.; Banaszkiewicz, M.; Pietrasik, A.; et al. Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: A multicentre registry. EuroIntervention 2022, 17, 1104–1111. [Google Scholar] [CrossRef]
- Ghofrani, H.A.; D’Armini, A.M.; Grimminger, F.; Hoeper, M.M.; Jansa, P.; Kim, N.H.; Mayer, E.; Simonneau, G.; Wilkins, M.R.; Fritsch, A.; et al. Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension. N. Engl. J. Med. 2013, 369, 319–329. [Google Scholar] [CrossRef]
- Sadushi-Kolici, R.; Jansa, P.; Kopec, G.; Torbicki, A.; Skoro-Sajer, N.; Campean, I.-A.; Halank, M.; Simkova, I.; Karlocai, K.; Steringer-Mascherbauer, R.; et al. Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): A double-blind, phase 3, randomised controlled trial. Lancet Respir. Med. 2019, 7, 239–248. [Google Scholar] [CrossRef] [PubMed]
- Ghofrani, H.A.; Simonneau, G.; D’Armini, A.M.; Fedullo, P.; Howard, L.S.; Jaïs, X.; Jenkins, D.P.; Jing, Z.-C.; Madani, M.M.; Martin, N.; et al. Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): Results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study. Lancet Respir. Med. 2017, 5, 785–794. [Google Scholar] [CrossRef]
- Kim, N.H.; Mayer, E. Chronic thromboembolic pulmonary hypertension: The evolving treatment landscape. Eur. Respir. Rev. 2015, 24, 173–177. [Google Scholar] [CrossRef] [PubMed]
- Stasch, J.P.; Pacher, P.; Evgenov, O.V. Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease. Circulation 2011, 123, 2263–2273. [Google Scholar] [CrossRef]
- Ordi-Ros, J.; Sáez-Comet, L.; Pérez-Conesa, M.; Vidal, X.; Riera-Mestre, A.; Castro-Salomó, A.; Cuquet-Pedragosa, J.; Ortiz-Santamaria, V.; Mauri-Plana, M.; Solé, C.; et al. Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome. Ann. Intern. Med. 2019, 171, 685. [Google Scholar] [CrossRef] [PubMed]
- Pengo, V.; Denas, G.; Zoppellaro, G.; Jose, S.P.; Hoxha, A.; Ruffatti, A.; Andreoli, L.; Tincani, A.; Cenci, C.; Prisco, D.; et al. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood 2018, 132, 1365–1371. [Google Scholar] [CrossRef]
- Konstantinides, S.V.; Meyer, G.; Becattini, C.; Bueno, H.; Geersing, G.J.; Harjola, V.P.; Huisman, M.V.; Humbert, M.; Jennings, C.S.; Jiménez, D.; et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur. Heart J. 2020, 41, 543–603. [Google Scholar] [CrossRef]
- Nagel, C.; Prange, F.; Guth, S.; Herb, J.; Ehlken, N.; Fischer, C.; Reichenberger, F.; Rosenkranz, S.; Seyfarth, H.-J.; Mayer, E.; et al. Exercise Training Improves Exercise Capacity and Quality of Life in Patients with Inoperable or Residual Chronic Thromboembolic Pulmonary Hypertension. PLoS ONE 2012, 7, e41603. [Google Scholar] [CrossRef]
- Nagel, C.; Nasereddin, M.; Benjamin, N.; Egenlauf, B.; Harutyunova, S.; Eichstaedt, C.A.; Xanthouli, P.; Mayer, E.; Grünig, E.; Guth, S. Supervised Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension as Early Follow-Up Treatment after Pulmonary Endarterectomy: A Prospective Cohort Study. Respiration 2020, 99, 577–588. [Google Scholar] [CrossRef]
Parameter | All CTEPH Patients n = 14 | Non-Operated Patients n = 10 | PEA-Operated Patients n = 4 |
---|---|---|---|
Age (years) (a) | 52.79 ± 13.64 | 55.80 ± 13.25 | 45.25 ± 13.17 |
Gender (female) (b) | 11 (78.57%) | 8 (80%) | 3 (75%) |
NYHA I & II (b) | 2 (14.28%) | 1 (10%) | 1 (25%) |
NYHA III (b) | 10 (71.42%) | 7 (70%) | 3 (75%) |
NYHA IV (b) | 2 (14.28%) | 2 (20%) | - |
Deaths (b) | 7 (50%) | 6 (60%) | 1 (25%) |
Age at death (years) (a) | 56.14 ± 11.90 | 56.16 ± 12.86 | 56.00 |
6MWT (meters) (a) | 330.64 ± 134.21 | 328.90 ± 134.73 | 335.00 ± 132.90 |
Duration of vasodilator treatment (years) (a) | 4.22 ± 3.62 | 3.88 ± 3.88 | 5.06 ± 1.99 |
NT-proBNP (pg/mL) (a) | 1838.07 ± 1011.44 | 1938.70 ± 1125.71 | 1586.5 ± 260.91 |
RHC mPAP (mmHg) (a) | 47.36 ± 8.78 | 46.90 ± 8.41 | 48.50 ± 8.44 |
RHC PVR (dynes/sec/cm−5) (a) | 972.80 ± 243.20 | 986.24 ± 259.76 | 940.00 ± 149.76 |
PE history (b) | 9 (64.28%) | 5 (50%) | 4 (100%) |
DVT history (b) | 11 (78.57%) | 8 (80%) | 3 (75%) |
Obesity (b) | 6 (42.85%) | 4 (40%) | 2 (50%) |
Thrombophilia (b) | 3 (21.42%) | 1 (10%) | 2 (50%) |
VKAs (b) | 12 (85.71%) | 8 (80%) | 4 (100%) |
NOACs (b) | 2 (14.28%) | 2 (20%) | - |
Monotherapy (b) | 9 (64.28%) | 8 (80%) | 1 (25%) |
Double therapy (b) | 3 (21.42%) | 2 (20%) | 1 (25%) |
Triple therapy (b) | 2 (14.28%) | - | 2 (50%) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bertici, R.A.; Bertici, N.S.; Ridichie, A.; Fira-Mladinescu, O. Comorbidities, Treatment and Survival Rates of Chronic Thromboembolic Pulmonary Hypertension in a Regional Centre. J. Clin. Med. 2024, 13, 2754. https://doi.org/10.3390/jcm13102754
Bertici RA, Bertici NS, Ridichie A, Fira-Mladinescu O. Comorbidities, Treatment and Survival Rates of Chronic Thromboembolic Pulmonary Hypertension in a Regional Centre. Journal of Clinical Medicine. 2024; 13(10):2754. https://doi.org/10.3390/jcm13102754
Chicago/Turabian StyleBertici, Razvan Adrian, Nicoleta Sorina Bertici, Amalia Ridichie, and Ovidiu Fira-Mladinescu. 2024. "Comorbidities, Treatment and Survival Rates of Chronic Thromboembolic Pulmonary Hypertension in a Regional Centre" Journal of Clinical Medicine 13, no. 10: 2754. https://doi.org/10.3390/jcm13102754
APA StyleBertici, R. A., Bertici, N. S., Ridichie, A., & Fira-Mladinescu, O. (2024). Comorbidities, Treatment and Survival Rates of Chronic Thromboembolic Pulmonary Hypertension in a Regional Centre. Journal of Clinical Medicine, 13(10), 2754. https://doi.org/10.3390/jcm13102754